Predicting Normal vs. Carrier Status in Euploid Embryos of Translocation Carriers

NCT02178865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2017-03-17

No results posted yet for this study

Summary

The purpose of this study is to assess the accuracy of predicting the normal or carrier status of human embryos resulting from in vitro-fertilization (IVF) from patients carrying a balanced translocation.

Conditions

  • Balanced Chromosomal Translocation

Sponsors & Collaborators

  • Reproductive Medicine Associates of New Jersey

    lead OTHER

Principal Investigators

  • Richard T Scott, MD, HCLD · Reproductive Medicine Associates of New Jersey

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-12-31
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178865 on ClinicalTrials.gov